Home » Topics » BioWorld

BioWorld
RSS

CALGENE TO TEST LAURATE-PRODUCING PLANT

Jan. 23, 1992

DNAP TOMATOES RESIST ROT

Jan. 23, 1992

USDA OKS CARRINGTON VACCINE ADJUVANT

Jan. 23, 1992

LIDAK CANCELS PLANS FOR SUBSIDIARY

Jan. 23, 1992

DOCTORS BLAST AMGEN'S G-CSF TRIAL

Jan. 23, 1992

YAMANOUCHI TO BUY STAKE IN ROBERTS

Jan. 23, 1992

SOMATIX GETS PATENT FOR GENE THERAPY

Jan. 23, 1992

IMMULOGIC RAISES $45.5 MILLION IN OFFERING

Jan. 22, 1992

INTERNEURON LICENSES DELIVERY TECHNOLOGY

Jan. 22, 1992

IN OVO VACCINATION SUCCESSFUL IN TESTS

Jan. 22, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...